D. Viñal

Impact of epidermal growth factor receptor (EGFR) activating mutations and their targeted treatment in the prognosis of stage IV non-small cell lung cancer (NSCLC) patients harboring liver metastasis

Eduardo Castañón, Christian Rolfo, D. Viñal et al. · Journal of Translational Medicine · 2015 · 36 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Incidence of venous thromboembolic events in cancer patients receiving immunotherapy: a single-institution experience

Laura Gutiérrez-Sainz, Virginia Martínez-Marín, D. Viñal et al. · Clinical & Translational Oncology · 2020 · 33 citations

Medicine, Hematology, Oncology +16

Prognostic value of neutrophil-to-lymphocyte ratio and other inflammatory markers in patients with high-risk soft tissue sarcomas

D. Viñal, D. Martínez, J. A. Garcia-Cuesta et al. · Clinical & Translational Oncology · 2020 · 27 citations

Medicine, Immunology, Oncology +14

Prognostic value of neutrophil-to-lymphocyte ratio in advanced cancer patients receiving immunotherapy

D. Viñal, Laura Gutiérrez-Sainz, D. Martínez et al. · Clinical & Translational Oncology · 2020 · 25 citations

Medicine, Hematology, Oncology +16

Epidemiology and natural history of cutaneous squamous cell carcinoma in recessive dystrophic epidermolysis bullosa patients: 20 years’ experience of a reference centre in Spain

Beatriz Castelo, D. Viñal, R. Maseda et al. · Clinical & Translational Oncology · 2019 · 21 citations

Medicine, Dermatology, Pathology +17